Commonwealth Retirement Investments LLC Makes New Investment in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE)

Commonwealth Retirement Investments LLC bought a new stake in iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) in the fourth quarter, Holdings Channel reports. The fund bought 8,157 shares of the company’s stock, valued at approximately $536,000.

Several other hedge funds also recently modified their holdings of IHE. Wealth Enhancement Advisory Services LLC increased its position in shares of iShares U.S. Pharmaceuticals ETF by 11.0% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 3,589 shares of the company’s stock worth $253,000 after acquiring an additional 356 shares in the last quarter. FMR LLC grew its stake in shares of iShares U.S. Pharmaceuticals ETF by 10.9% in the 3rd quarter. FMR LLC now owns 13,581 shares of the company’s stock valued at $959,000 after buying an additional 1,338 shares in the last quarter. Jane Street Group LLC lifted its stake in iShares U.S. Pharmaceuticals ETF by 5.5% in the third quarter. Jane Street Group LLC now owns 11,846 shares of the company’s stock valued at $836,000 after acquiring an additional 616 shares during the last quarter. Thrivent Financial for Lutherans grew its position in iShares U.S. Pharmaceuticals ETF by 23.6% in the third quarter. Thrivent Financial for Lutherans now owns 32,509 shares of the company’s stock worth $2,295,000 after acquiring an additional 6,214 shares in the last quarter. Finally, Patten & Patten Inc. TN increased its stake in shares of iShares U.S. Pharmaceuticals ETF by 9.5% during the 3rd quarter. Patten & Patten Inc. TN now owns 25,813 shares of the company’s stock worth $1,823,000 after purchasing an additional 2,245 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Trading Up 0.7 %

IHE stock opened at $72.01 on Tuesday. The firm has a market cap of $727.30 million, a PE ratio of 6.49 and a beta of 0.58. The company has a fifty day simple moving average of $67.90 and a 200 day simple moving average of $69.30. iShares U.S. Pharmaceuticals ETF has a 1 year low of $62.67 and a 1 year high of $72.94.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.